McKesson updates automated Oklahoma hub plan, shares trade near record levels
26.06.2026 - 09:36:06 | ad-hoc-news.de
By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-26, 09:35.
McKesson (US58155Q1031) is advancing plans for a new highly automated pharmaceutical distribution hub in Moore, Oklahoma. The NYSE-listed healthcare distributor is targeting expanded capacity across Oklahoma, Texas and neighboring states with the project, as highlighted in a recent Simply Wall St note.
Automated Oklahoma hub in focus
According to a Simply Wall St analysis, McKesson is investing in a regional distribution center in Moore that will use high levels of automation to modernize its drug logistics network across the southern United States. The facility is intended to bolster supply-chain reliability for pharmacies, hospitals and health systems in the region.
The report underlines that the Oklahoma hub is designed to increase efficiency and support additional volume, building on McKesson’s existing US distribution footprint. For a distributor that already handles a significant share of US prescription drug flows, added automated capacity can lower handling costs and support service levels for large customers such as health systems and retail pharmacy chains.
Shares near highs and below targets
McKesson shares on the NYSE recently changed hands around 763.81 US dollars, with MarketBeat data showing a close at 764.77 dollars on 25 June 2026. Over the past three years, Simply Wall St calculates a total share price return of about 84 percent and roughly 307 percent over five years, underscoring a strong long-term performance.
The same Simply Wall St piece notes that the shares trade around 19 percent below the consensus analyst price target of 941.40 dollars, indicating a gap between current pricing and average sell-side expectations. At the same time, that source describes the stock valuation as very rich relative to its internal fair-value model, emphasizing the tension between momentum, analyst targets and certain valuation screens.
All news and key data on the McKesson shares
Further figures, news and filings on McKesson can be found in the ad-hoc-news topic overview and in the company’s investor-relations section.
How McKesson makes its money
McKesson’s core business revolves around pharmaceutical distribution, delivering branded and generic medicines, specialty drugs and medical-surgical supplies to retail pharmacies, hospitals, physician offices and health systems across the US. The group also offers technology and services for oncology and other specialty practices, as well as pharmacy management and automation solutions for large healthcare customers.
Where the shares trade today
The McKesson shares (US58155Q1031) traded on the NYSE at 764.77 US dollars as of 2026-06-25, 15:59 Eastern Time.
Key data on the McKesson shares
- Company: McKesson Corporation
- ISIN: US58155Q1031
- WKN: 893953
- Ticker: MCK
- Trading venue: NYSE
- Price (as of 2026-06-25, 15:59): 764.77 USD
- Market cap: 101.4 billion USD (as of 2026-06-25)
- Sector / industry: Healthcare distribution / pharmaceuticals wholesaling
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any kind. Figures and dates are based on publicly available sources cited in the text and may change over time.
